Status:
WITHDRAWN
An Early Feasibility Evaluation of a Novel 3rdMolarTooth Bud Ablation Procedure
Lead Sponsor:
TriAgenics Inc
Conditions:
Molar, Third
Eligibility:
All Genders
7-13 years
Phase:
NA
Brief Summary
This single-arm prospective study will enroll a minimum of 7 and a maximum 10 subjects between the ages of 7 and 13 years of age with radiographic evidence of mandibular 3rd molar tooth bud developmen...
Eligibility Criteria
Inclusion
- Subject is between 7 and 13 years of age
- Subject has radiographic evidence of at least one mandibular 3rd molar tooth bud
Exclusion
- Subject use of articaine is contraindicated (known hypersensitive to products containing sulfites).
- Subject has any condition which, in the opinion of the Investigator, would prevent adequate performance of the procedure or affect the health and/or safety of the subject.-
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05374993
Start Date
November 1 2022
End Date
July 1 2023
Last Update
April 12 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.